期刊
JOURNAL OF CELL BIOLOGY
卷 192, 期 3, 页码 373-382出版社
ROCKEFELLER UNIV PRESS
DOI: 10.1083/jcb.201010021
关键词
-
类别
资金
- Howard Hughes Medical Institute Funding Source: Medline
- NIBIB NIH HHS [P41 EB002503] Funding Source: Medline
Circulating tumor cells (CTCs) shed from primary and metastatic cancers are admixed with blood components and are thus rare, making their isolation and characterization a major technological challenge. CTCs hold the key to understanding the biology of metastasis and provide a biomarker to noninvasively measure the evolution of tumor genotypes during treatment and disease progression. Improvements in technologies to yield purer CTC populations amenable to better cellular and molecular characterization will enable a broad range of clinical applications, including early detection of disease and the discovery of biomarkers to predict treatment responses and disease progression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据